Rivaflo 2.5 Tablet
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Rivaroxaban (2.5mg)
Overview Rivaflo 2.5 Tablet
A blood thinner, marketed as Rivaflo 2.5 Tablet, counteracts blood clot formation, thereby mitigating the risk of stroke and heart attack. Its application extends to preventing and treating clots in leg, lung, brain, and heart veins. Frequently prescribed for individuals with atrial fibrillation to prevent clotting, it also safeguards against clot development post-knee or hip replacement. This medication can be ingested with or without food, ideally at the same time daily for optimal efficacy. Long-term use, potentially lifelong, may be necessary; discontinuing or altering the dosage without physician consultation significantly increases the risk of stroke, heart attack, or thrombosis. Lifestyle modifications, including diet, exercise, smoking cessation, and weight management, further reduce clot risk. Increased bleeding propensity (e.g., nosebleeds, bruising) is a common side effect; report any adverse reactions promptly. Contraindicated in individuals with severe hepatic or renal dysfunction, active bleeding, or concurrent use of other anticoagulants. Breastfeeding is not advised during treatment. Unlike many similar medications, routine PT-INR monitoring is unnecessary.
Primary Ingredients of Rivaflo 2.5 Tablet
No text provided. Please provide the text you want me to rephrase.
Uses of Rivaflo 2.5 Tablet
Preventing and managing blood clots.
Major Benefits of Rivaflo 2.5 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Rivaflo 2.5 Tablet whole; avoid crushing, chewing, or breaking it. While this medication can be taken with or without food, consistency is key—take it at the same time each day.
Common Side effects of Rivaflo 2.5 Tablet:
- Bleeding
How to use Rivaflo 2.5 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Rivaflo 2.5 Tablet whole; avoid chewing, crushing, or breaking it. While this medication can be taken with or without food, consistent timing is recommended.
How Rivaflo 2.5 Tablet works:
Xarelto 2.5mg is an innovative oral blood thinner. Its mechanism of action involves inhibiting factor Xa, a crucial component in blood coagulation, thereby reducing the risk of dangerous clot formation.
SAFETY ADVICE
AlcoholCAUTION
Combining Rivaflo 2.5 Tablet and alcohol requires careful consideration. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
Use of Rivaflo 2.5 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Rivaflo 2.5 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Rivaflo 2.5 Tablet, which can induce dizziness or fainting. Side effects from Rivaflo 2.5 Tablet may include dizziness and loss of consciousness, impacting the ability to operate a vehicle.
KidneyCAUTION
Patients with impaired kidney function should use Rivaflo 2.5mg tablets cautiously, potentially requiring a modified dosage. Medical advice is essential. Rivaflo 2.5mg tablets are contraindicated for individuals with severely compromised kidney function.
LiverUNSAFE
Patients with liver conditions should likely refrain from using Rivaflo 2.5 Tablet due to potential safety concerns. A physician's consultation is recommended.
What if you forget to take Rivaflo 2.5 Tablet :
Should you forget to take a Rivaflo 2.5 Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Rivaflo 2.5 Tablet
| Label | Value |
|---|---|
| Chemical Category | Morpholine- and thiophene-based derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | Xa Inhibitors for Oral Administration |



